US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist

145.280
-0.410-0.28%

Close Jul 22 16:00 ET

145.280
0.0000.00%

Post 16:20 ET

14.62BMarket Cap39.48P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

204.07%130.3M

14.88%389.9M

-13.64%123.5M

114.57%212M

30.05%179.6M

-209.14%-125.2M

32.32%339.4M

3,304.76%143M

59.87%98.8M

33.82%138.1M

Net income from continuing operations

156.66%43.4M

61.62%249.7M

65.96%147.7M

21.31%83.1M

665.09%95.5M

-651.08%-76.6M

72.43%154.5M

1,319.18%89M

204.44%68.5M

-139.95%-16.9M

Operating gains losses

----

--70M

--0

----

Depreciation and amortization

24.00%6.2M

36.54%21.3M

29.55%5.7M

37.50%5.5M

30.77%5.1M

51.52%5M

43.12%15.6M

46.67%4.4M

42.86%4M

50.00%3.9M

Deferred tax

50.63%-15.6M

-396.86%-56.7M

52.59%20.6M

-146.67%-4.2M

-1,238.71%-41.5M

-10,433.33%-31.6M

344.19%19.1M

387.23%13.5M

57.89%9M

-132.63%-3.1M

Other non cash items

92,200.00%92.1M

-112.50%-200K

616.67%12.4M

-800.00%-6.3M

-426.32%-6.2M

-108.33%-100K

-88.81%1.6M

61.90%-2.4M

-86.15%900K

-73.97%1.9M

Change In working capital

45.04%-31.6M

141.84%28.2M

-3,480.00%-53.7M

394.87%46M

267.72%93.4M

24.04%-57.5M

-503.59%-67.4M

-130.61%-1.5M

25.71%-15.6M

96.90%25.4M

-Change in receivables

72.90%-11.3M

44.94%-89.3M

53.98%-21.4M

-36.94%-30.4M

127.10%4.2M

46.54%-41.7M

-471.13%-162.2M

-114.29%-46.5M

-318.87%-22.2M

-44.86%-15.5M

-Change in inventory

-38.89%1.1M

307.69%5.4M

-123.08%-900K

137.66%2.9M

633.33%1.6M

20.00%1.8M

-4.00%-2.6M

178.00%3.9M

-375.00%-7.7M

-116.67%-300K

-Change in payables and accrued expense

-377.61%-18.6M

-43.89%64.3M

-320.74%-83M

279.27%124.4M

-50.46%16.2M

-41.74%6.7M

101.76%114.6M

96.86%37.6M

277.01%32.8M

81.67%32.7M

-Change in other working capital

88.48%-2.8M

377.91%47.8M

1,374.29%51.6M

-175.14%-50.9M

740.00%71.4M

-127.10%-24.3M

-86.96%-17.2M

-72.00%3.5M

31.99%-18.5M

123.68%8.5M

Cash from discontinued investing activities

Operating cash flow

204.07%130.3M

14.88%389.9M

-13.64%123.5M

114.57%212M

30.05%179.6M

-209.14%-125.2M

32.32%339.4M

3,304.76%143M

59.87%98.8M

33.82%138.1M

Investing cash flow

Cash flow from continuing investing activities

-30.64%-55M

-163.75%-467.1M

-74.57%-201.8M

-58.73%-97.3M

-500.96%-125.9M

-33.23%-42.1M

-36.02%-177.1M

-587.76%-115.6M

51.43%-61.3M

134.58%31.4M

Capital expenditure reported

-31.76%-11.2M

-71.52%-28.3M

-200.00%-5.4M

-547.06%-7.6M

22.73%-6.8M

-11.84%-8.5M

29.49%-16.5M

79.78%-1.8M

--1.7M

---8.8M

Net business purchase and sale

----

--0

----

---42.7M

----

Net investment purchase and sale

-30.36%-43.8M

-272.18%-438.8M

-176.23%-196.4M

-42.38%-89.7M

-396.27%-119.1M

-40.00%-33.6M

-10.39%-117.9M

-318.10%-71.1M

47.72%-63M

146.47%40.2M

Cash from discontinued investing activities

Investing cash flow

-30.64%-55M

-163.75%-467.1M

-74.57%-201.8M

-58.73%-97.3M

-500.96%-125.9M

-33.23%-42.1M

-36.02%-177.1M

-587.76%-115.6M

51.43%-61.3M

134.58%31.4M

Financing cash flow

Cash flow from continuing financing activities

752.44%69.9M

127.87%65.3M

43.90%35.4M

64.91%18.8M

101.05%2.9M

34.43%8.2M

-955.11%-234.3M

1,266.67%24.6M

52.00%11.4M

-9,313.33%-276.4M

Net issuance payments of debt

----

--0

----

-278,900.00%-279M

--0

----

Proceeds from stock option exercised by employees

752.44%69.9M

46.09%65.3M

43.90%35.4M

64.91%18.8M

11.54%2.9M

34.43%8.2M

62.55%44.7M

1,266.67%24.6M

52.00%11.4M

-13.33%2.6M

Cash from discontinued financing activities

Financing cash flow

752.44%69.9M

127.87%65.3M

43.90%35.4M

64.91%18.8M

101.05%2.9M

34.43%8.2M

-955.11%-234.3M

1,266.67%24.6M

52.00%11.4M

-9,313.33%-276.4M

Net cash flow

Beginning cash position

-4.29%259.1M

-21.31%270.7M

37.14%301.7M

-1.69%168.2M

-59.86%111.6M

-21.31%270.7M

80.77%344M

-30.00%220M

-53.91%171.1M

-21.87%278M

Current changes in cash

191.26%145.2M

83.47%-11.9M

-182.50%-42.9M

173.01%133.5M

152.95%56.6M

-141.06%-159.1M

-146.84%-72M

75.08%52M

185.94%48.9M

-794.16%-106.9M

Effect of exchange rate changes

----

123.08%300K

----

---1.3M

----

End cash Position

262.28%404.3M

-4.29%259.1M

37.14%301.7M

-1.69%168.2M

-59.86%111.6M

-21.31%270.7M

-30.00%220M

-53.91%171.1M

Free cash flow

189.08%119.1M

11.99%361.6M

-16.36%118.1M

103.38%204.4M

33.64%172.8M

-177.96%-133.7M

38.52%322.9M

3,104.26%141.2M

79.14%100.5M

30.74%129.3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	204.07%130.3M	14.88%389.9M	-13.64%123.5M	114.57%212M	30.05%179.6M	-209.14%-125.2M	32.32%339.4M	3,304.76%143M	59.87%98.8M	33.82%138.1M
Net income from continuing operations	156.66%43.4M	61.62%249.7M	65.96%147.7M	21.31%83.1M	665.09%95.5M	-651.08%-76.6M	72.43%154.5M	1,319.18%89M	204.44%68.5M	-139.95%-16.9M
Operating gains losses	----	----	----	----	----	----	--70M	--0	--0	----
Depreciation and amortization	24.00%6.2M	36.54%21.3M	29.55%5.7M	37.50%5.5M	30.77%5.1M	51.52%5M	43.12%15.6M	46.67%4.4M	42.86%4M	50.00%3.9M
Deferred tax	50.63%-15.6M	-396.86%-56.7M	52.59%20.6M	-146.67%-4.2M	-1,238.71%-41.5M	-10,433.33%-31.6M	344.19%19.1M	387.23%13.5M	57.89%9M	-132.63%-3.1M
Other non cash items	92,200.00%92.1M	-112.50%-200K	616.67%12.4M	-800.00%-6.3M	-426.32%-6.2M	-108.33%-100K	-88.81%1.6M	61.90%-2.4M	-86.15%900K	-73.97%1.9M
Change In working capital	45.04%-31.6M	141.84%28.2M	-3,480.00%-53.7M	394.87%46M	267.72%93.4M	24.04%-57.5M	-503.59%-67.4M	-130.61%-1.5M	25.71%-15.6M	96.90%25.4M
-Change in receivables	72.90%-11.3M	44.94%-89.3M	53.98%-21.4M	-36.94%-30.4M	127.10%4.2M	46.54%-41.7M	-471.13%-162.2M	-114.29%-46.5M	-318.87%-22.2M	-44.86%-15.5M
-Change in inventory	-38.89%1.1M	307.69%5.4M	-123.08%-900K	137.66%2.9M	633.33%1.6M	20.00%1.8M	-4.00%-2.6M	178.00%3.9M	-375.00%-7.7M	-116.67%-300K
-Change in payables and accrued expense	-377.61%-18.6M	-43.89%64.3M	-320.74%-83M	279.27%124.4M	-50.46%16.2M	-41.74%6.7M	101.76%114.6M	96.86%37.6M	277.01%32.8M	81.67%32.7M
-Change in other working capital	88.48%-2.8M	377.91%47.8M	1,374.29%51.6M	-175.14%-50.9M	740.00%71.4M	-127.10%-24.3M	-86.96%-17.2M	-72.00%3.5M	31.99%-18.5M	123.68%8.5M
Cash from discontinued investing activities
Operating cash flow	204.07%130.3M	14.88%389.9M	-13.64%123.5M	114.57%212M	30.05%179.6M	-209.14%-125.2M	32.32%339.4M	3,304.76%143M	59.87%98.8M	33.82%138.1M
Investing cash flow
Cash flow from continuing investing activities	-30.64%-55M	-163.75%-467.1M	-74.57%-201.8M	-58.73%-97.3M	-500.96%-125.9M	-33.23%-42.1M	-36.02%-177.1M	-587.76%-115.6M	51.43%-61.3M	134.58%31.4M
Capital expenditure reported	-31.76%-11.2M	-71.52%-28.3M	-200.00%-5.4M	-547.06%-7.6M	22.73%-6.8M	-11.84%-8.5M	29.49%-16.5M	79.78%-1.8M	--1.7M	---8.8M
Net business purchase and sale	----	--0	----	----	----	----	---42.7M	----	----	----
Net investment purchase and sale	-30.36%-43.8M	-272.18%-438.8M	-176.23%-196.4M	-42.38%-89.7M	-396.27%-119.1M	-40.00%-33.6M	-10.39%-117.9M	-318.10%-71.1M	47.72%-63M	146.47%40.2M
Cash from discontinued investing activities
Investing cash flow	-30.64%-55M	-163.75%-467.1M	-74.57%-201.8M	-58.73%-97.3M	-500.96%-125.9M	-33.23%-42.1M	-36.02%-177.1M	-587.76%-115.6M	51.43%-61.3M	134.58%31.4M
Financing cash flow
Cash flow from continuing financing activities	752.44%69.9M	127.87%65.3M	43.90%35.4M	64.91%18.8M	101.05%2.9M	34.43%8.2M	-955.11%-234.3M	1,266.67%24.6M	52.00%11.4M	-9,313.33%-276.4M
Net issuance payments of debt	----	--0	--0	--0	----	----	-278,900.00%-279M	--0	--0	----
Proceeds from stock option exercised by employees	752.44%69.9M	46.09%65.3M	43.90%35.4M	64.91%18.8M	11.54%2.9M	34.43%8.2M	62.55%44.7M	1,266.67%24.6M	52.00%11.4M	-13.33%2.6M
Cash from discontinued financing activities
Financing cash flow	752.44%69.9M	127.87%65.3M	43.90%35.4M	64.91%18.8M	101.05%2.9M	34.43%8.2M	-955.11%-234.3M	1,266.67%24.6M	52.00%11.4M	-9,313.33%-276.4M
Net cash flow
Beginning cash position	-4.29%259.1M	-21.31%270.7M	37.14%301.7M	-1.69%168.2M	-59.86%111.6M	-21.31%270.7M	80.77%344M	-30.00%220M	-53.91%171.1M	-21.87%278M
Current changes in cash	191.26%145.2M	83.47%-11.9M	-182.50%-42.9M	173.01%133.5M	152.95%56.6M	-141.06%-159.1M	-146.84%-72M	75.08%52M	185.94%48.9M	-794.16%-106.9M
Effect of exchange rate changes	----	123.08%300K	----	----	----	----	---1.3M	----	----	----
End cash Position	262.28%404.3M	-4.29%259.1M	-4.29%259.1M	37.14%301.7M	-1.69%168.2M	-59.86%111.6M	-21.31%270.7M	-21.31%270.7M	-30.00%220M	-53.91%171.1M
Free cash flow	189.08%119.1M	11.99%361.6M	-16.36%118.1M	103.38%204.4M	33.64%172.8M	-177.96%-133.7M	38.52%322.9M	3,104.26%141.2M	79.14%100.5M	30.74%129.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall